Similar articles

• Tamoxifen-associated steatohepatitis--report of three cases.

  Pinto HC, Baptista A, Camilo ME, de Costa EB, Valente A, de Moura MC. Pinto HC, et al. J Hepatol. 1995 Jul;23(1):95-7. doi: 10.1016/0168-8278(95)80316-5. J Hepatol. 1995. PMID: 8530816
• [A case of metastatic breast cancer successfully treated with weekly low-dose epirubicin (EPI), cyclophosphamide (CPA), 5-fluorouracil (5-FU) and medroxyprogesterone (MPA)].

  Satoh Y, Une Y, Fujisawa J, Uchino J. Satoh Y, et al. Gan To Kagaku Ryoho. 1994 Oct;21(14):2509-12. Gan To Kagaku Ryoho. 1994. PMID: 7944500 Japanese.
• [Viral Hepatitis A over imposed on chronic hepatic damage due to tamoxifen: report of a case].

  Vildozola H, Vargas G, Takano J. Vildozola H, et al. Rev Gastroenterol Peru. 2007 Jan-Mar;27(1):67-71. Rev Gastroenterol Peru. 2007. PMID: 17431437 Review. Spanish.
• Epirubicin-induced primary Sjögren's syndrome.

  Oxholm A, Frederiksen PL, Oxholm P. Oxholm A, et al. Lancet. 1986 Sep 13;2(8507):629-30. doi: 10.1016/s0140-6736(86)92452-9. Lancet. 1986. PMID: 2875341 No abstract available.
• [Adjuvant therapy of breast cancer with tamoxifen and endometrial carcinoma].

  Mignotte H, Sasco AJ, Lasset C, Saez S, Rivoire M, Bobin JY. Mignotte H, et al. Bull Cancer. 1992;79(10):969-77. Bull Cancer. 1992. PMID: 1292764 Review. French.